ACRS - Aclaris Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACRS is currently covered by 1 analysts with an average price target of $16. This is a potential upside of $9.4 (180.21%) from yesterday's end of day stock price of $5.71.

Aclaris Therapeutics's activity chart (see below) currently has 30 price targets and 49 ratings on display. The stock rating distribution of ACRS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20.63% with an average time for these price targets to be met of 66.31 days.

Highest price target for ACRS is $16, Lowest price target is $16, average price target is $16.

Most recent stock forecast was given by from HC WAINWRIGHT on 19-Mar-2026. First documented stock forecast 02-Nov-2015.

Currently out of the existing stock ratings of ACRS, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-May-2025

$16

$11 (220.00%)

$16

3 months 21 days ago
(19-Mar-2026)

0/11 (0%)

$12.26 (327.81%)

Hold Since 06-Nov-2024

$2

$-3 (-60.00%)

$3

1 years 4 months 13 days ago
(27-Feb-2025)

3/5 (60%)

$0.05 (2.56%)

77

Hold Since 20-Nov-2024

1 years 7 months 20 days ago
(20-Nov-2024)

0/10 (0%)

$23.92 (169.89%)

Hold Since 19-Nov-2024

$8

$3 (60.00%)

1 years 7 months 21 days ago
(19-Nov-2024)

0/4 (0%)

$3.41 (74.29%)

Hold Since 19-Nov-2024

$7

$2 (40.00%)

1 years 7 months 21 days ago
(19-Nov-2024)

0/5 (0%)

$2.41 (52.51%)

Show more analysts

Please expand the browser size to see the chart

What is ACRS (Aclaris Therapeutics) average time for price targets to be met?

On average it took 66.31 days on average for the stock forecasts to be realized with a an average price target met ratio 20.63

Which analyst has the current highest performing score on ACRS (Aclaris Therapeutics) with a proven track record?

DAVID STEINBERG

Which analyst has the most public recommendations on ACRS (Aclaris Therapeutics)?

David Steinberg has 4 price targets and 2 ratings on ACRS

Which analyst is the currently most bullish on ACRS (Aclaris Therapeutics)?

Seamus Fernandez with highest potential upside - $47.96

Which analyst is the currently most reserved on ACRS (Aclaris Therapeutics)?

Alex Thompson with lowest potential downside - -$3.56

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?